dpp4 and glp 1 interaction Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus Discovery and development of dipeptidyl

2,3,4,5 Liraglutide belongs to the class of glucagon-like peptide 1 receptor agonists ( GLP-1 RAs ) that are recommended in the treatment guidelines by the American Diabetes Association as well as the American Association of Clinical Endocrinology (AACE) Consensus Statement & European Society of Cardiology for type 2 diabetes mellitus patients with co-morbidities, like established atherosclerotic cardiovascular disease and obesity

10.1097/00001756-199906030-00004 95 OlshanskyS

Key Personnel 15.1.5

Mattson MP, Perry T, Greig NH

$429-$1078 Available In-Clinic & Mobile $60-$289 Available In-Clinic & Mobile The cost of NAD IV therapy typically ranges from around $400 to over $1,000 per session depending on dosage, infusion time and delivery method